F.D.A. Looks to A.I. to Enhance Efficiency

Health
By Christina Jewett from NYT Health https://ift.tt/oZqGbvn
via IFTTT Regulation and Deregulation of Industry, Artificial Intelligence, United States Politics and Government, Federal Budget (US), Drugs (Pharmaceuticals), Coronavirus (2019-nCoV), Food, Medical Devices With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda